Title : Multicenter phase II study of SOX plus trastuzumab for patients with HER2+ metastatic or recurrent gastric cancer: KSCC/HGCSG/CCOG/PerSeUS 1501B.

Pub. Date : 2020 Jan

PMID : 31768696






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 We conducted the first phase II trial among four Japanese study groups to assess the efficacy and safety of T-mab + S-1 and oxaliplatin (T-SOX130) for HER2+ AGC or recurrent gastric cancer. Oxaliplatin erb-b2 receptor tyrosine kinase 2 Homo sapiens